Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance

Go back to Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance
(NYSE: TDOC) Delayed: 6.37 +0.07 (1.11%)
Previous Close $6.30    52 Week High $22.00 
Open $6.28    52 Week Low $9.08 
Day High $6.41    P/E N/A 
Day Low $6.28    EPS $0.00 
Volume 550,826